VSR Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$987K Buy
13,424
+71
+0.5% +$5.02K 0.16% 170
2016
Q1
$853K Buy
13,353
+332
+3% +$20.9K 0.09% 246
2015
Q4
$896K Buy
13,021
+35
+0.3% +$2.31K 0.1% 229
2015
Q3
$769K Buy
12,986
+1
+0% +$63 0.09% 233
2015
Q2
$864K Sell
12,985
-302
-2% -$19.9K 0.09% 247
2015
Q1
$857K Buy
13,287
+198
+2% +$12.4K 0.09% 249
2014
Q4
$773K Sell
13,089
-3,493
-21% -$197K 0.09% 252
2014
Q3
$849K Buy
16,582
+1,195
+8% +$59.7K 0.1% 227
2014
Q2
$746K Sell
15,387
-12,844
-45% -$633K 0.09% 252
2014
Q1
$1.47M Buy
28,231
+1,629
+6% +$86.7K 0.21% 120
2013
Q4
$1.41M Buy
26,602
+10,167
+62% +$518K 0.22% 110
2013
Q3
$761K Buy
16,435
+24
+0.1% +$1.05K 0.13% 178
2013
Q2
$733K Buy
+16,411
New +$712K 0.14% 169

Other funds holding BMY

VSR Financial Services's BMY Position: Q2 2016 in Review

VSR Financial Services increased its Bristol-Myers Squibb (BMY) stake by 0.53% in Q2 2016, buying an estimated $5.02K and bringing the position to 13,424 shares worth $987K. The position accounts for 0.16% of the portfolio, ranked #170.

VSR Financial Services first reported a position in BMY in Q2 2013 and has held it in 13 quarters since. The position peaked at $1.47M in Q1 2014. 1,576 funds tracked by Wall St. Rank hold BMY as of Q2 2016.

  • VSR Financial Services held 13,424 shares of Bristol-Myers Squibb worth $987K as of Q2 2016.
  • VSR Financial Services bought 71 Bristol-Myers Squibb shares in Q2 2016, an estimated $5.02K.
  • Bristol-Myers Squibb made up 0.16% of VSR Financial Services's portfolio in Q2 2016, its #170 holding.
  • VSR Financial Services first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 13 quarters since.
  • VSR Financial Services's Bristol-Myers Squibb position peaked at $1.47M in Q1 2014.
  • 1,576 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2016.

Based on VSR Financial Services's 13F filing for Q2 2016, filed 11 Aug 2016.